Skip Navigation LinksHome > January 2013 - Volume 21 - Issue 1 > Successful Treatment of Osteomyelitis From Methicillin-Resis...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e31825b2110
Case Reports

Successful Treatment of Osteomyelitis From Methicillin-Resistant Staphylococcus Aureus With Ceftaroline

Watkins, Richard R. MD, MS, FACP

Collapse Box


Abstract: Osteomyelitis due to methicillin-resistant Staphylococcus aureus (MRSA) is a challenging illness to treat because of limited antibiotic options. Ceftaroline is a novel cephalosporin with activity against MRSA. It is currently approved for the treatment of adults with community-acquired pneumonia (but not from MRSA) and bacterial skin and skin structure infections. This case report describes a patient with osteomyelitis from MRSA cured with ceftaroline.

© 2013 Lippincott Williams & Wilkins, Inc.

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.